Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.

MLA

Capalbo, A., et al. “Clinical Validity and Utility of Preconception Expanded Carrier Screening for the Management of Reproductive Genetic Risk in IVF and General Population.” Human Reproduction (Oxford, England), vol. 36, no. 7, June 2021, pp. 2050–61. EBSCOhost, https://doi.org/10.1093/humrep/deab087.

APA

Capalbo, A., Fabiani, M., Caroselli, S., Poli, M., Girardi, L., Patassini, C., Favero, F., Cimadomo, D., Vaiarelli, A., Simon, C., Rienzi, L. F., & Ubaldi, F. M. (2021). Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population. Human Reproduction (Oxford, England), 36(7), 2050–2061. https://doi.org/10.1093/humrep/deab087

Chicago

Capalbo, A, M Fabiani, S Caroselli, M Poli, L Girardi, C Patassini, F Favero, et al. 2021. “Clinical Validity and Utility of Preconception Expanded Carrier Screening for the Management of Reproductive Genetic Risk in IVF and General Population.” Human Reproduction (Oxford, England) 36 (7): 2050–61. doi:10.1093/humrep/deab087.